Evidence map›Paper›PMID 27072616›Full record

ReviewMatrix biology : journal of the International Society for Matrix Biology

Biglycan potentially regulates angiogenesis during fracture repair by altering expression and function of endostatin.

Maja Myren, David J Kirby, Megan L Noonan, Azusa Maeda, Rick T Owens, Sylvie Ricard-Blum, Vardit Kram, Tina M Kilts, Marian F Young

Open access · greenAbstract readReview
In one paragraph

Review in Matrix biology : journal of the International Society for Matrix Biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Biglycan stimulates retinal pathological angiogenesis via up-regulation of CXCL12 expression in pericytes.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  4. Article
  5. The role of proteoglycan form of DMP1 in cranial repair.BMC molecular and cell biology · 2022
    Article
  6. Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders.International journal of molecular sciences · 2022
    Review
  7. Expression and the Prognostic Value of Biglycan in Gastric Cancer.Computational and mathematical methods in medicine · 2022
    Article
  8. Review
  9. A functional outside-in signaling network of proteoglycans and matrix molecules regulating autophagy.Matrix biology : journal of the International Society for Matrix Biology · 2021
    Article
  10. Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2020
    Review
  11. Biglycan in the Skeleton.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2020
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. The Influence of TGF-β3, EGF, and BGN on SOX9 and RUNX2 Expression in Human Chondrogenic Progenitor Cells.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2019
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Maja MyrenCraniofacial and Skeletal Diseases Branch, NIDCR, NIH, Bethesda, MD 20892, United States.
David J KirbyCraniofacial and Skeletal Diseases Branch, NIDCR, NIH, Bethesda, MD 20892, United States.
Megan L NoonanCraniofacial and Skeletal Diseases Branch, NIDCR, NIH, Bethesda, MD 20892, United States.
Azusa MaedaCraniofacial and Skeletal Diseases Branch, NIDCR, NIH, Bethesda, MD 20892, United States.
Rick T OwensLife Cell Corporation, Branchburg, NJ 08876, United States.
Sylvie Ricard-BlumUniversity of Lyon, UMR 5246 CNRS - University Lyon 1, ICBMS, 69622 Villeurbanne, France.
Vardit KramCraniofacial and Skeletal Diseases Branch, NIDCR, NIH, Bethesda, MD 20892, United States.
Tina M KiltsCraniofacial and Skeletal Diseases Branch, NIDCR, NIH, Bethesda, MD 20892, United States.
Marian F YoungCraniofacial and Skeletal Diseases Branch, NIDCR, NIH, Bethesda, MD 20892, United States. Electronic address: Myoung@dir.nidcr.nih.gov.
Florida Craniofacial Institute · USNational Institute of Dental and Craniofacial Research · USInstitut de Chimie et Biochimie Moléculaires et Supramoléculaires · FR

Funding

Function Of Skeletal Matrix GenesZIADE000379 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI YOUNG, MARIAN F · 2009 to 2023
$23.6M
STRUCTURE AND BONE MATRIX GENE EXPRESSIONZ01DE000379 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI YOUNG, MARIAN F · 1985 to 2008
$2.5M
Intramural NIH HHS Z01 DE000379
6 · The paper itself

Abstract

The small proteoglycan biglycan (Bgn) is highly expressed in the organic matrix of bone and plays a role in bone formation. Previous work implicated Bgn in vessel growth during bone healing [1]. By infusing barium sulfate (BaSO4) into WT and Bgn-deficient mice we discovered the positive effect of Bgn in modulating angiogenesis during fracture healing. Using micro-computed tomography angiography we found significant differences in the vessel size and volume among other parameters. To further understand the mechanistic basis for this, we explored the relationship between Bgn and the anti-angiogenic protein endostatin. Immunohistochemistry (IHC) showed co-localization of Bgn and endostatin in regions of bone formation, with increased endostatin staining in Bgn-KO compared to WT at 14days post-fracture. To further elucidate the relationship between Bgn and endostatin, an endothelial cell tube formation assay was used. This study showed that endothelial cells treated with endostatin had significantly decreased vessel length and vessel branches compared to untreated cells, while cells treated with endostatin and Bgn at a 1:1M ratio had vessel length and vessel branches comparable to untreated cells. This indicated that Bgn was able to mitigate the inhibitory effect of endostatin on endothelial cell growth. In summary, these results suggest that Bgn is needed for proper blood vessel formation during fracture healing, and one mechanism by which Bgn impacts angiogenesis is through inhibition of endostatin.

Indexed as

Down-RegulationFracture HealingNeovascularization, PhysiologicAnimalsBiglycanComputed Tomography AngiographyEndostatinsEndothelial CellsGene Knockout TechniquesMiceX-Ray MicrotomographyBgn protein, mouseBiglycanEndostatinsAngiogenesisBiglycanEndostatinFracture healing

Identifiers

PMID27072616
PMCPMC4875882
OpenAlexW2316771288

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.